Patents by Inventor Mark David Fidock

Mark David Fidock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040137500
    Abstract: Polynucleotide and polypeptide sequences are described. The polypeptide sequences comprise one or more of: (a) a polypeptide having the deduced amino acid sequence translated from the polynucleotide sequence in SEQ ID NO: 1 and variants, fragments, homologues, analogues and derivatives thereof; (b) a polypeptide of SEQ ID NO: 2 and variants, fragments, homologues, analogues and derivatives thereof.
    Type: Application
    Filed: January 23, 2004
    Publication date: July 15, 2004
    Applicant: Pfizer Inc
    Inventor: Mark David Fidock
  • Publication number: 20040137574
    Abstract: Polynucleotide and polypeptide sequences are described. The polypeptide sequences comprise one or more of: (a) a polypeptide having the deduced amino acid sequence translated from the polynucleotide sequence in SEQ ID NO: 1 and variants, fragments, homologues, analogues and derivatives thereof; (b) a polypeptide of SEQ ID NO: 2 and variants, fragments, homologues, analogues and derivatives thereof.
    Type: Application
    Filed: January 22, 2004
    Publication date: July 15, 2004
    Applicant: Pfizer Inc
    Inventor: Mark David Fidock
  • Publication number: 20030171293
    Abstract: This invention relates to the identification of an orphan G-protein coupled receptor MRGX2 (and variants thereof) as a receptor of neuropeptides such as but not limited to cortistatin, somatostatin, Bam 13-22, &agr;-MSH, neuropeptide FF, dynorphin A and substance P, and the use of such neuropeptides (and structurally related molecules) as modulators for MRGX2. It also relates to screening methods to identify agonists and antagonists for this neuropeptide receptor.
    Type: Application
    Filed: February 24, 2003
    Publication date: September 11, 2003
    Applicant: Pfizer Inc.
    Inventors: Nicola Melanie Robas, Mark David Fidock
  • Publication number: 20030166882
    Abstract: Polynucleotide and polypeptide sequences are described. The polypeptide sequences comprise one or more of: (a) a polypeptide having the deduced amino acid sequence translated from the polynucleotide sequence in SEQ ID NO: 1 and variants, fragments, homologues, analogues and derivatives thereof; (b) a polypeptide of SEQ ID NO: 2 and variants, fragments, homologues, analogues and derivatives thereof.
    Type: Application
    Filed: December 18, 2001
    Publication date: September 4, 2003
    Inventor: Mark David Fidock
  • Publication number: 20030024000
    Abstract: The invention features transgenic non-human mammals and transgenic cells expressing a radical fringe transgene comprising a radical fringe coding sequence, wherein expression of said coding sequence in said mammal is driven by an operably linked regulatory sequence that directs inducible and keratinocyte-specific expression, and wherein said mammal exhibits accelerated wound healing and/or increased keratinocyte proliferation following the induction of transgene expression. The invention also features polynucleotide and amino acid sequences for human radical fringe, methods of treating psoriasis and promoting wound healing by administering a modulator of radical fringe polypeptide activity, and methods of identifying modulators of radical fringe activity.
    Type: Application
    Filed: July 16, 2002
    Publication date: January 30, 2003
    Applicant: Pfizer Inc.
    Inventors: Martyn Frank Burslem, Mark David Fidock
  • Publication number: 20030022282
    Abstract: Polynucleotide and polypeptide sequences are described. The polypeptide sequences comprise one or more of: (a) a polypeptide having the deduced amino acid sequence translated from the polynucleotide sequence in SEQ ID NO: 1 and vanants, fragments, homologues, analogues and derivatives thereof; (b) a polypeptide of SEQ ID NO: 2 and variants, fragments, homologues, analogues and derivatives thereof.
    Type: Application
    Filed: December 18, 2001
    Publication date: January 30, 2003
    Inventor: Mark David Fidock